The Claim
In hypercholesterolemic adults who are either on high-dose statins or have heterozygous familial hypercholesterolemia, administration of AMG 145 at a dose of 140 mg every 2 weeks results in approximately a 75% reduction in low-density lipoprotein cholesterol (LDL-C) at the end of the dosing interval, demonstrating efficacy in high-risk patient subgroups with limited treatment options.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A drug called AMG 145, when given every two weeks, cuts bad cholesterol by about three-quarters in people with high cholesterol who are already on strong meds or have a genetic form of the condition — even when their options are limited.
See the scientific wording
AMG 145 at a dose of 140 mg administered every 2 weeks causes approximately 75% reduction in LDL-C at the end of the dosing interval in hypercholesterolemic adults on high-dose statins or with heterozygous familial hypercholesterolemia, demonstrating efficacy in high-risk patient subgroups with limited treatment options.
What the research says
1 studyThe study tested the same medicine and dose mentioned in the claim and found it greatly lowered bad cholesterol, especially in high-risk patients, which supports the claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.